Myomo price target lowered to $8 from $10 at Craig-Hallum

Craig-Hallum lowered the firm’s price target on Myomo (MYO) to $8 from $10 and keeps a Buy rating on the shares following the company’s investor day. Management outlined a target of $100M in revenue by 2028, notes the analyst, who is moderating the firm’s 2025 revenue estimate to account for the potential for a slower recovery in cost-per-pipeline add. However, weakness in the shares is “overdone” given the company’s strong growth and long-term growth potential, the analyst added.